Captor Capital Reports Higher Revenues and Lower Expenses in Unaudited Interim Financial Statements for the Three Months Ended September 30, 2019

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), an integrated cannabis company, today released its interim financial statements and quarterly MD&A for the three months ended September 30, 2019. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. The Company…

Read More

Why Canopy Growth (TSX:WEED) Stock Is Being Pummeled Again

The release of second-quarter fiscal 2020 results yesterday felt a little like Canopy Growth’s (TSX:WEED)(NYSECGC) day of reckoning in a long list of days that have felt the same. Canopy Growth stock is down approximately 15% at the time of writing on the day of the release. That’s pretty brutal and feels like a wake-up call. Let’s take a look…

Read More

3 Takeaways From Canopy Growth’s (TSX:WEED) Horrible Quarterly Earnings

Leading marijuana growth stock Canopy Growth (TSX:WEED)(NYSE:CGC) released its anticipated fiscal second quarter 2020 results early on Thursday. In the midst of the largely bad news report were some small grains of hope-inducing numbers. Second-quarter gross revenue had grown 6% sequentially quarter over quarter to a respectable $118.3 million, but there were some necessary charges to the revenue line of…

Read More

5 Important Takeaways From Cronos Group’s (TSX:CRON) Latest Quarterly Earnings

A sequential quarterly net revenue growth of 24% and a 214% jump in quarterly net earnings to $788 million could top the highlights for Cronos Group’s (TSX:CRON)(NASDAQ:CRON) latest financial report delivered early on Tuesday, but there was a lot to chew in the company’s latest quarterly results. Let’s just quickly get down to it. Revenue growth was aided Cronos reported…

Read More

New York Gets a Taste of iDrink

SUIC and iDrink Expand Again — this time Into the Big Apple by Michael Kryton, EQUITY IR contributing writer Having established themselves in Southeast Asia, SUIC (Sino United Worldwide Consolidated OTC: SUIC) and iDrink Technology have boldly stepped up their marketing initiatives with a move into New York to install two iDrink smart beverage vending machines. iDrink is becoming known…

Read More

ALERT: 1 Week Before Aurora Cannabis (TSX:ACB) Earnings

We are a few weeks removed from the next stage of cannabis legalization. Cannabis 2.0 will introduce products like vape pens and edibles into the legal market. Aurora Cannabis (TSX:ACB)(NYSE:ACB), one of the top producers in the world, has seen its stock fall 15.7% month over month. According to Aurora’s upcoming events on its main site, the company is set…

Read More

3 Reasons “Cannabis 2.0” Is Ridiculously Overrated

This past October, “Cannabis 2.0” was all the rage, as speculation circulated about how the legalization of edibles and concentrates would affect cannabis producers. The new laws impact a number of product categories that were previously illegal to sell — even with the federal legalization of cannabis last year. When cannabis was initially legalized, marijuana producers’ revenue exploded on the…

Read More

New to Cannabis? 2 Promising Pot Stocks for Beginners

The cannabis market is set for massive growth. You probably already know that, yet the numbers are worth repeating. Over the next decade, global sales are expected to grow by more than 20% per year. By 2030, some analysts believe the market will be worth $100 billion. Research firms like Stifel Financial think it can ultimately reach $200 billion in annual…

Read More

Should You Buy HEXO (TSX:HEXO) Stock at $3?

The rout in the share prices of Canadian marijuana stocks continues to drive down valuations in the cannabis sector, which  has contrarian investors wondering if the sell-off might be overdone. Let’s take a look at HEXO (TSX:HEXO)(NYSE:HEXO) to see if it deserves to be on your buy list today. Revenue woes HEXO has a credibility issue. The company just reported…

Read More

Could Canopy Growth (TSX:WEED) Still Hit $1 Billion in Sales?

This past January, Canopy Growth’s (TSX:WEED)(NYSE:CGC) biggest investor, Constellation Brands, said that they expected the company to reach $1 billion in revenue no later than 2020. Citing the company’s fast revenue growth, they believed it was only a matter of time before the company hit the billion-dollar sales club. However, after posting a series of disappointing quarterly reports, Canopy’s sales forecast has…

Read More